Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Nov 27, 2020)
Date Submitted: Nov 16, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Live Video Mind-Body Treatment to Prevent Persistent Symptoms Following Mild Traumatic Brain Injury: Protocol for a Mixed-Methods Study
ABSTRACT
Background:
Every year, approximately 42 million people suffer a mild traumatic brain injury (mTBI, aka concussion), with particularly high rates among college-age individuals. A substantial proportion (44%-64%) go on to develop persistent symptoms that are challenging to treat, costly, and associated with significant disability. Anxiety has emerged as risk factor for progression from acute to persistent mTBI symptoms.
Objective:
This study aims to develop, adapt, and establish the feasibility of the Toolkit for Optimal Recovery after Concussions (TOR-C), an innovative mind-body program aimed at preventing persistent symptoms among young adults with mTBI and co-morbid anxiety. Here we describe the proposed study design, methodology, measurement, and treatment manuals.
Methods:
In phase 1 we will conduct individual, live video qualitative interviews (up to N=20) with college-age individuals with mTBI and comorbid anxiety to inform adaptation of the intervention and study procedures. In phase 2, we will conduct an open pilot of the live video TOR-C (N=5) with exit interviews to explore initial feasibility, acceptability, and credibility of the program and to refine study procedures. In phase 3 we will conduct a feasibility randomized controlled trial (N= 50) of the TOR-C versus a health education control (Health Enhancement for Concussions; HE-C), both delivered via live video, to establish 1) feasibility of recruitment procedures (screening, eligibility, enrollment) and data collection; 2), feasibility, credibility, and acceptability of the live video TOR-C and HE-C (adherence, retention, fidelity, satisfaction) following pre-specified benchmarks, and 3) a signal of improvement in outcomes.
Results:
Phase 1 of the study was approved by the Massachusetts General Hospital Institutional Review Board. Study completion is anticipated by early 2025.
Conclusions:
We will develop and test the first mind-body intervention focused on prevention of persistent symptoms following mTBI in young adults with comorbid anxiety problems. It will allow us to establish feasibility markers in post-concussive symptoms, anxiety, disability, and fear avoidance, to inform a future efficacy trial of TOR-C vs. the HE-C and subsequent implementation.
Citation
The author of this paper has made a PDF available, but requires the user to login, or create an account.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.